Document:

Exhibit 10.3

EMPLOYMENT AGREEMENT

 

 

This Employment Agreement (the "Agreement") is entered into as of the 14th day of September, 2017 (the "Effective Date"), by and between Chembio Diagnostics, Inc., a Nevada corporation (the "Company"), and Sharon Klugewicz ("Employee"). Employee and the Company are sometimes referred to individually as a "Party" and collectively as the "Parties".

 

In consideration of the mutual covenants, promises and agreements herein contained, the Company and Employee hereby covenant, promise and agree to and with each other as follows:

 

1. Employment. The Company shall employ Employee and Employee shall perform services for and on behalf of the Company upon the terms and conditions set forth in this Agreement.

2. Positions and Duties of Employment.  Employee shall be required to devote her full energy, skill and best efforts as required to the furtherance of her managerial duties with the Company as the Company's President, Americas Region. While serving in such capacities, Employee shall have the responsibilities, duties, obligations, rights, benefits and requisite authority as is customary for her position and as may be determined by the Company's Board of Directors (the "Board").

 

Employee understands that her employment as President, Americas Region of the Company involves a high degree of trust and confidence, that she is employed for the purpose of furthering the Company's reputation and improving the Company's operations and profitability, and that in executing this Agreement she undertakes the obligations set forth herein to accomplish such objectives. Employee agrees that she shall serve the Company fully, diligently, competently and to the best of her ability. Employee certifies that she fully understands her right to discuss this Agreement with her attorney, that she has availed herself of this right to the extent that she desires, that she has carefully read and fully understands this entire Agreement, and that she is voluntarily entering into this Agreement.

 

3. Duties. Employee shall perform the following services for the Company:

 

(a) Employee shall serve as President, Americas Region of the Company, or in such other position as determined by the Board, and in those capacities shall work with the Company to pursue the Company's plans as directed by the Board.

 

(b) Employee shall perform duties with the functions of an officer of the Company, subject to the direction of the Board.

 

(c) During the Term (as defined in Section 4 below) of this Agreement, Employee shall devote substantially all of Employee's business time to the performance of Employee's duties under this Agreement. Without limiting the foregoing, Employee shall perform services on behalf of the Company for at least forty hours per week, and Employee shall be reasonably available at the request of the Company at other times, including weekends and holidays, to meet the needs and requests of the Company's customers.

(d) During the Term, Employee will not engage in any other activities or undertake any other commitments that conflict with or take priority over Employee's responsibilities and obligations to the Company and the Company's customers, including without limitation those responsibilities and obligations incurred pursuant to this Agreement.

 

4. Term. Unless terminated earlier as provided for in this Agreement, the term of this Agreement shall be for one year, commencing on the Effective Date and ending on the first anniversary of the Effective Date (the "Term"). If the employment relationship is terminated by either Party, Employee agrees to cooperate with the Company and with the Company's new management with respect to the transition of the new management in the operations previously performed by Employee. Upon Employee's termination, Employee agrees to return to the Company all Company documents (and all copies thereof), any other Company property in Employee's possession or control, and any materials of any kind that contain or embody any proprietary or confidential material of the Company.

5. Compensation.  As compensation for the services to be performed by Employee during the Term, Company shall pay Employee the following a compensation:

(a) A base salary at an annual rate of $280,000, subject to periodic review by the Board or the Compensation Committee of the Board (the "Committee"), payable in accordance with the Company's customary payroll practices (the "Base Salary").

 

(b) A performance-based bonus (the "Performance Bonus") of up to 37.5% of the Base Salary, to be comprised of the same components in the same ratios as for the Company's other executive officers.

 

6. Certain Additional Provisions Relating to Compensation and Other Employee Benefits.

(a) If Employee is eligible, the Company shall include Employee in any profit sharing plan, executive stock option plan, long term incentive program, pension plan, retirement plan, medical and/or hospitalization plan, and/or any and all other benefit plans, except for disability and life insurance, which may be placed in effect by the Company for the benefit of the Company's executive officers during the Term. Except for the fact that the Company at all times shall provide employee with all or at least a portion of Employee's medical and/or hospitalization insurance, which shall not be less than that afforded to the Company's other executive officers, nothing in this Agreement shall limit (i) the Company's ability to exercise the discretion provided to it under any such benefit plan, or (ii) the Company's discretion to adopt, not adopt, amend or terminate any such benefit plan at any time.

(b) Employee shall be entitled to four (4) weeks vacation leave for each year of the Term, as well as sick leave, medical insurance coverage and any other benefits consistent with the Company's plans and policies in effect for the Company's executives from time to time. The Company may modify in its sole and absolute discretion such benefits from time to time as it considers necessary or appropriate.

(c) During the Term, Employee shall be reimbursed for reasonable expenses that are authorized by the Company and that are incurred by Employee for the benefit of the Company in accordance with the standard reimbursement practices of the Company. Any direct payment or reimbursement of expenses shall be made only upon presentation of an itemized accounting conforming in form and content to standards prescribed by the Internal Revenue Service relative to the substantiation of the deductibility of business expenses.

(d) Any payments which the Company shall make to Employee pursuant to this Agreement shall be reduced by standard withholding and other applicable payroll deductions, including, without limitation, federal, state or local income or other taxes, social security and medicare taxes, state unemployment insurance deductions, state disability insurance deductions, and any other applicable tax or deduction (collectively, any withheld taxes and deductions, "Deductions").

 

7. Confidentiality.

 

(a) Employee hereby warrants, covenants and agrees that, without the prior express written consent of the Company, and unless required by law, court order or similar process, Employee shall hold in the strictest confidence, and shall not disclose to any person, firm, corporation or other entity, any and all of the Company's information, including, for example, and without limitation, any data related to (i) drawings, sketches, plans or other documents concerning the Company's business or development plans, customers or suppliers, and research and development efforts; (ii) the Company's development, design, construction or sales and marketing methods or techniques; or (iii) the Company's trade secrets and other "know-how" or information not of a public nature, regardless of how such information came to the custody of Employee (collectively, subsections (i), (ii) and (iii) of this Section 7(a), "Information"). For purposes of this Agreement, such Information shall include, but not be limited to, any information regarding a formula, pattern, compilation, program, device, method, technique or process that (A) derives independent economic value, present or potential, not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use, and (B) is the subject of Company efforts.

(b) In the event Employee is required by law, court order or similar process to disclose any Information, Employee shall provide immediate notice of such obligatory disclosure prior to such disclosure, so that the Company, at its sole option, may attempt to seek a protective order or other appropriate remedy to preclude such disclosure.

(c) The warranties, covenants and agreements set forth in this Section 8 shall not expire, shall survive this Agreement, and shall be binding upon Employee without regard to the passage of time or any other event.

 

8. Company's Right To Inventions and Discoveries

(a) "Inventions" means all improvements, discoveries, inventions, works of authorship, mask works, computer programs, source and object codes, writings, formulas, ideas, processes, techniques, know-how and data, made or conceived or reduced to practice or developed by Employee, either alone or jointly with others as a result of employment at the Company.  "Proprietary Rights" means all trade secret, patent, copyright, trademark, trade name, service mark, and other intellectual property rights throughout the world. Inventions and Proprietary Rights do not include inventions that the Employee developed entirely on Employee's own time without using the Company's equipment, supplies, facilities, or Information except for those inventions that either relate to the Company's actual or anticipated business, research or development or that result from work performed by the Employee for the Company.

(b) Employee hereby assigns and agrees to assign in the future to the Company all of Employee's right, title and interest in and to any and all Inventions and all Proprietary Rights, whether or not subject to protection under the patent, copyright, trademark or industrial design laws, made or conceived or reduced to practice or learned by Employee (solely or jointly with others) during Employee's employment with the Company (including, without limitation such employment prior to the Effective Date) and for a one-year period after Employee's termination of employment with the Company (collectively "Assigned Intellectual Property"). Employee further agrees that all Assigned Intellectual Property is the sole property of the Company.

(c) Employee agrees to promptly notify and fully disclose to the Company all Assigned Intellectual Property, and will take such steps as are deemed necessary to maintain complete and current records of same. Employee will, at the Company's request and expense, whether during or after employment, take such steps as are reasonably necessary to assist the Company in securing, maintaining, defending or enforcing any title and right to Assigned Intellectual Property.

 

9. Non-Compete. Employee acknowledges and recognizes the highly competitive nature of the Company's business and that Employee's duties hereunder justify restricting Employee's further employment following any termination of employment.  Employee further acknowledges and understands that the Company recognizes Employee's importance and value to the Company and thus has provided Employee with the overall compensation package described hereunder in order to induce Employee to enter into this Agreement.  Accordingly, Employee agrees that so long as Employee is employed by the Company, and (i) for a period of two (2) years following the termination of this Agreement, Employee shall not induce or attempt to induce any employee of the Company to leave the employ of the Company, or in any way interfere with the relationship between the Company and any other employee; (ii) for a period of one (1) year following the termination of this Agreement, Employee, except when acting at the request of the Company on behalf of or for the benefit of the Company, shall not induce customers, agents or other sources of distribution of the Company's business under contract or doing business with the Company to terminate, reduce, alter or divert business with or from the Company; and (iii) for a period of one (1) year following the termination of this Agreement, Employee shall not, directly or indirectly, either as a principal, agent, employee, employer, consultant, partner, member or manager of a limited liability company, shareholder of a company that does not have securities registered under the Securities Exchange Act of 1934 (the "1934 Act"), or a shareholder in excess of one (1%) percent of a company that has securities registered under the 1934 Act, corporate officer or director, or in any other individual or representative capacity, engage or otherwise participate in any manner or fashion in any business that directly competes with the business activities of the Company in or about any market in which the Company is, or has publicly announced a plan for doing business.  Employee further covenants and agrees that the restrictive covenants set forth in this paragraph are reasonable as to duration, terms, and geographical area and that the same protects the legitimate interests of the Company, imposes no undue hardship on Employee, and is not injurious to the public.  The covenant set forth under (iii) above shall not apply if Employee's employment is terminated within twelve (12) months of a Change in Control.  Ownership by Employee, for investment purposes only, of less than one (1%) percent of any class of securities of a corporation if said securities are listed on a national securities exchange or registered under the 1934 Act shall not constitute a breach of the covenant set forth under (iii) above.  Employee acknowledges and understands that, by virtue of her position with the Company, she will have exposure to various entities with which the Company does business or is in discussions to do business.  Accordingly, Employee hereby covenants and agrees that, so long as she is employed by the Company, she will not, except with the prior written consent of the Company, solicit or enter into any discussions for a position of employment with any such entities.  It is the desire and intent of the Parties that the provisions of this paragraph be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular portion of this paragraph shall be adjudicated to be invalid or enforceable, this paragraph shall be deemed amended to apply in the broadest allowable manner and to delete therefrom the portion adjudicated to be invalid or unenforceable, such amendment and deletion to apply only with respect to the operation of this paragraph in the particular jurisdiction in which that adjudication is made.

10. Internal Revenue Code Section 409A ("409A") Matters. this Agreement is intended to comply with 409A any ambiguous provisions will be construed in a manner that is compliant with or exempt from the application of 409A.  If a provision of the Agreement would result in the imposition of an applicable tax under 409A, the parties agree that such provision shall be reformed to avoid imposition of the applicable tax, with such reformation effected in a manner that has the most favorable result to Employee.

(a) For purposes of 409A, each payment or amount due under this Agreement shall be considered a separate payment, and Employee's entitlement to a series of payments under this Agreement is to be treated as an entitlement to a series of separate payments.

(b) If (x) Employee is a "specified employee," as such term is defined in 409A and determined as described below in this Paragraph 10(b), and (y) any payment due under this Agreement is subject to 409A and is required to be delayed under 409A because Employee is a specified employee, that payment shall be payable on the earlier of (A) the first business day that is six months after Employee's separation from service, as such term is defined in 409A, (B) the date of Employee's death, or (C) the date that otherwise complies with the requirements of 409A.  this Paragraph 10(b) shall be applied by accumulating all payments that otherwise would have been paid within six months of Employee's separation and paying such accumulated amounts on the earliest business day which complies with the requirements of 409A.  For purposes of determining the identity of specified employees, the Board may establish procedures as it deems appropriate in accordance with 409A.

11. Termination.

 

(a) If Employee's employment is terminated by the Company without Cause, or if Employee terminates her employment for Reasonable Basis (as defined below), then the Company shall, in exchange for Employee's execution of a general release and waiver of claims against the Company as of the termination date in a form reasonably acceptable to the Company, continue to pay as severance Employee's Base Salary for a period of six months following the date such general release and waiver of claims is executed. Such payments shall be made in accordance with the Company's customary payroll practices, and shall be subject to all applicable Deductions. In the event of any such termination set forth in this Section 11(a), Employee will not be entitled to any additional cash compensation or benefits beyond what is provided in the first sentence of this Section 12(a).

 

	
(i)

	
For purposes of this Agreement, "Cause" shall mean that the Board, acting in good faith based upon the information then known to the Company, determines that Employee has engaged in or committed any of the following: (A) willful misconduct, gross negligence, theft, fraud, or other illegal conduct; (B) refusal or unwillingness to perform Employee's duties; (C) performance by Employee of Employee's duties determined by the Board to be inadequate in a material respect; (D) breach of any applicable non-competition provision, confidentiality provision or other proprietary information or inventions agreement between Employee and the Company; (E) inappropriate conflict of interest; (F) insubordination; (G) failure to follow the directions of the Board or any committee thereof; (H) any other material breach of this Agreement. In addition, an indictment or conviction of any felony, or any entry of a plea of nolo contendre, under the laws of the United States or any State shall be considered "Cause" hereunder. "Cause" shall be specified in a notice of termination to be delivered by the Company to Employee no later than the date as of which termination is effective.

	
(ii)

	
For purposes of this Agreement, "Reasonable Basis" shall mean (A) a material breach of this Agreement by the Company, provided, however, that Employee shall provide written notice to the Company of any alleged material breach, and any alleged material breach will only be considered a material breach if the Company fails to cure such breach within thirty days after receiving notice of such breach; (B) termination of Employee's employment by the Company without Cause during the term hereof; (C) a reduction in Employee's salary, except to the extent that a majority of the other executive officers of the Company incur reductions of salary that average no less than the percentage reduction incurred by Employee; (D) without Employee's consent, a material reduction in Employee's title, duties, or responsibilities; or (E) termination of Employee's employment by Employee within six (6) months after a "Change of Control," which is defined as any of the following:

	
(1)

	
any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation, other than a merger of the Company in which the holders of the Company's voting common stock immediately prior to the merger own a majority of the voting common stock of the surviving corporation immediately after the merger;

 

	
(2)

	
any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all the assets of the Company;

 

	
(3)

	
any approval by the stockholders of the Company of any plan or proposal for the liquidation or dissolution of the Company;

 

	
(4)

	
the acquisition by any person or entity, or any group of persons and/or entities of a majority of the stock entitled to elect a majority of the directors of the Company; or

 

	
(5)

	
subject to applicable law, in a Chapter 11 bankruptcy proceeding, the appointment of a trustee or the conversion of a case involving the Company to a case under a Chapter 7 bankruptcy proceeding.

(b) In the event that Employee's employment with the Company is terminated for Cause, by reason of Employee's death or disability, or due to Employee's resignation or voluntary termination (other than for a Reasonable Basis), then all compensation (including, without limitation, any Base Salary, and the right to receive a Performance Bonus, and benefits, and the vesting of any unvested Restricted Options, will cease as of the effective date of such termination, and Employee shall receive no severance benefits, or any other compensation; provided that Employee shall be entitled to receive all compensation earned and all benefits and reimbursements due through the effective date of termination.

 

(c) Employee agrees that the payments contemplated by this Agreement shall constitute the exclusive and sole remedy for any termination of employment, and Employee covenants not to assert or pursue any other remedies, at law or in equity, with respect to any termination of employment.

(d) Any Party terminating this Agreement shall give prompt written notice to the other Party hereto advising such other Party of the termination of this Agreement stating in reasonable detail the basis for such termination (the "Notice of Termination"). The Notice of Termination shall indicate whether termination is being made for Cause (if the Company has terminated the Agreement) or for a Reasonable Basis (if Employee has terminated the Agreement).

 

12. Remedies. If there is a breach or threatened breach of any provision of Section 7, 8, 9, or 11 of this Agreement, the Company will suffer irreparable harm and shall be entitled to an injunction restraining Employee from such breach. Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies for such breach or threatened breach.

 

13. Severability.  It is the clear intention of the Parties to this Agreement that no term, provision or clause of this Agreement shall be deemed to be invalid, illegal or unenforceable in any respect, unless such term, provision or clause cannot be otherwise construed, interpreted, or modified to give effect to the intent of the Parties and to be valid, legal or enforceable. The Parties specifically charge the trier of fact to give effect to the intent of the Parties, even if in doing so, invalidation of a specific provision of this Agreement is required to make the Agreement consistent with the foregoing stated intent. In the event that a term, provision, or clause cannot be so construed, interpreted or modified, the validity, legality and enforceability of the remaining provisions contained herein and other application(s) thereof shall not in any way be affected or impaired thereby and shall remain in full force and effect.

 

14. Waiver of Breach.  The waiver by the Company or Employee of the breach of any provision of this Agreement by the other Party shall not operate or be construed as a waiver of any subsequent breach by that Party.

 

15. Entire Agreement.  this document contains the entire agreement between the Parties and supersedes all prior oral or written agreements, if any, concerning the subject matter hereof or otherwise concerning Employee's employment by the Company (except with respect to shares, and options to purchase shares, of the Company's Common Stock previously granted to Employee). this Agreement may not be changed orally, but only by a written agreement signed by both Parties.

16. Governing Law.  this Agreement, its validity, interpretation and enforcement, shall be governed by the laws of the State of New York, excluding conflict of laws principles. Employee hereby expressly consents to personal jurisdiction in the state and federal courts located in Suffolk County, NY for any lawsuit filed there against him by the Company arising from or relating to this Agreement.

 

17. Notices.  Any notice pursuant to this Agreement shall be validly given or served if that notice is made in writing and delivered personally or sent by certified mail or registered, return receipt requested, postage prepaid, to the following addresses:

 

If to Company: Chembio Diagnostics, Inc.

 

3661 Horseblock Road, Suite A

 

Medford, NY  11763

Attention: Chief Executive Officer

 

If to Employee: To the address for Employee

set forth below her signature.

 

All notices so given shall be deemed effective upon personal delivery or, if sent by certified or registered mail, five business days after date of mailing or, if sent by overnight courier, one business day after dispatch. Either Party, by notice so given, may change the address to which her or its future notices shall be sent.

 

 

18. Assignment and Binding Effect.  this Agreement shall be binding upon Employee and the Company and shall benefit the Company and its successors and assigns. this Agreement shall not be assignable by Employee.

 

19. Headings.  The headings in this Agreement are for convenience only; they form no part of this Agreement and shall not affect its interpretation.

 

20. Construction.  Employee represents she has (a) read and completely understands this Agreement and (b) had an opportunity to consult with such legal and other advisers as she has desired in connection with this Agreement. This Agreement shall not be construed against any one of the Parties.

21. Directors' and Officers' Insurance.  The Company is to maintain directors' and officers' insurance in an amount reasonably determined by the Board.

22. Key Man Insurance.  The Company has purchased, or may purchase, one or more "key man" insurance policies on Employee's life, each of which will be payable to and owned by the Company.  The Company, in its sole discretion, may select the amount and type of key man life insurance purchased, and Employee will have no interest in any such policies.  Employee will cooperate with the Company in securing and maintaining this key man insurance by submitting to all required medical examinations, supplying all information and executing all documents required in order for the Company to secure and maintain the insurance.

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed on the respective dates set forth below to be effective as of May 22, 2015.

 

	
Employee:

 

Sharon Klugewicz, Individually

 

3661 Hoseblock Road 

Medford, NY  11763 

 

 

Date: 

	
Company:

 

Chembio Diagnostics, Inc.

 

By: 

John J. Sperzel III, Chief Exeutive Officer

 

 

Date:EX-10.1

 Exhibit 10.1 

AMENDMENT NO. 5 

AMENDMENT NO. 5, dated as of November 8, 2017 (this “Amendment”), to the Loan Agreement dated as of April 29,
2016, as amended by Amendment No. 1, dated as of August 17, 2016, Amendment No. 2, dated as of September 22, 2016, Amendment No. 3, dated as of March 14, 2017 and Amendment No. 4, dated as of March 23, 2017
(as further amended, supplemented, amended and restated or otherwise modified from time to time) (the “Loan Agreement”) among WESTERN DIGITAL CORPORATION, a Delaware corporation (the “Borrower”), each lender from
time to time party thereto (collectively, the “Lenders” and individually, a “Lender”), JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”) and
Collateral Agent and the other parties thereto. Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in the Loan Agreement. 

WHEREAS, Section 2.16 of the Loan Agreement provides that the Borrower may, by written notice to the Administrative Agent, incur
Refinancing Term Loans, the proceeds of which are used to refinance in whole or in part any Class of Term Loans pursuant to Section 2.8(c)(i) of the Loan Agreement, by entering into Refinancing Amendments with Lenders willing to provide
such Refinancing Term Loans; 
 WHEREAS, the Borrower desires, pursuant to Section 2.16(a) of the Loan Agreement, to create a new
Class of U.S. Term B-3 Loans (as defined herein) under the Loan Agreement having identical terms with and having the same rights and obligations under the Loan Documents as, and in the same aggregate
principal amount as, the U.S. Term B-2 Loans (after giving effect to the Prepayment), as set forth in the Loan Agreement and Loan Documents, except as such terms are amended hereby; 

WHEREAS, each U.S. Term B-2 Lender that executes and delivers a consent substantially in the form of
Exhibit A hereto (a “Consent”) to exchange all (or such lesser amount allocated to it by the Administrative Agent) of its U.S Term B-2 Loans outstanding for U.S. Term B-3 Loans upon effectiveness of this Amendment and thereafter become a U.S. Term B-3 Lender, shall be deemed have consented to this Amendment; 

WHEREAS, each Person that executes and delivers a joinder to this Amendment substantially in the form of Exhibit B (a
“Joinder”) as an Additional U.S. Term B-3 Lender will make U.S Term B-3 Loans in the amount set forth on the signature page of such Person’s
Joinder on the effective date of this Amendment to the Borrower, the proceeds of which will be used by the Borrower to repay in full the outstanding principal amount of Non-Exchanged U.S. Term B-2 Loans (as defined herein); 
 WHEREAS, Merrill Lynch, Pierce, Fenner & Smith Incorporated
(“Merrill Lynch”), Mizuho Bank, Ltd. (“Mizuho”), J.P. Morgan Securities LLC (“J.P. Morgan”), Wells Fargo Securities, LLC, RBC Capital Markets (“RBCCM”), HSBC Securities (USA) Inc.
(“HSBC”) and The Bank of Tokyo-Mitsubishi UFJ, Ltd. (“Bank of Tokyo”) will act as joint lead 

 
arrangers and joint bookrunners, Merrill Lynch, Mizuho, J.P. Morgan, Wells Fargo Bank, National Association, RBCCM, HSBC and Bank of Tokyo will act as
co-syndication agents, The Bank of Nova Scotia, BNP Paribas Sec. Corp., Sumitomo Mitsui Banking Corporation, Compass Bank d/b/a BBVA Compass, TD Securities (USA) LLC, U.S. Bank National Association and
SunTrust Robinson Humphrey, Inc. will act as co-documentation agents and Fifth Third Bank and Standard Chartered Bank will act as co-managing agents, in each case, for
the U.S. Term B-3 Facility (as defined below); 
 NOW, THEREFORE, in consideration of the premises
and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows: 

Section 1.    Amendments Relating to the U.S. Term B-3 Loans.

 Effective as of the Amendment No. 5 Effective Date, the Loan Agreement is hereby amended as follows: 

(a)    The following defined terms shall be added to Section 1.1 of the Loan Agreement in alphabetical order: 

“Additional U.S. Term B-3 Lender” means a Person with an Additional
U.S. Term B-3 Commitment to make Additional U.S. Term B-3 Loans to the Borrower on the Amendment No. 5 Effective Date. 

“Additional U.S. Term B-3 Loan” means a Loan that is made pursuant to
Section 2.1(d) of the Loan Agreement on the Amendment No. 5 Effective Date. 
 “Additional U.S. Term B-3 Commitment” means, with respect to an Additional U.S. Term B-3 Lender, the commitment of such Additional U.S. Term B-3
Lender to make an Additional U.S. Term B-3 Loan hereunder on the Amendment No. 5 Effective Date, in the amount set forth on the signature page of such Additional Term
B-3 Lender to the Amendment No. 5 Joinder. The aggregate amount of the Additional U.S. Term B-3 Commitments of all Additional U.S. Term B-3 Lenders shall equal the outstanding aggregate principal amount of Non-Exchanged U.S. Term B-2 Loans. 

“Amendment No. 5” means Amendment No. 5 to the Loan Agreement dated as of the
Amendment No. 5 Effective Date. 
 “Amendment No. 5 Effective Date” means
November 8, 2017, the date on which all conditions precedent set forth in Section 3 of Amendment No. 5 are satisfied. 

“Amendment No. 5 Joinder” means the Joinder Agreement dated as of the Amendment No. 5
Effective Date among the Borrower, the Administrative Agent and each Additional U.S. Term B-3 Lender. 

“Exchanged U.S. Term B-2 Loans” means each U.S. Term B-2 Loan extended on the Amendment No. 3 Effective Date (or portion thereof) and held by a Rollover U.S. 

  
 2 

 
Term B-2 Lender on the Amendment No. 5 Effective Date immediately prior to the extension of credit hereunder on the Amendment No. 5 Effective
Date and as to which the Rollover U.S. Term B-2 Lender thereof has consented to exchange into a U.S. Term B-3 Loan and the Administrative Agent has allocated into a U.S.
Term B-3 Loan. 
 “Non-Exchanged U.S.
Term B-2 Loan” means each U.S. Term B-2 Loan extended on the Amendment No. 3 Effective Date (or portion thereof) other than an Exchanged U.S. Term B-2 Loan. 
 “Rollover U.S. Term B-2
Lender” means each U.S Term B-2 Lender with a U.S Term B-2 Loan extended on the Closing Date that has consented to exchange such U.S. Term B-2 Loan into a U.S. Term B-3 Loan, and that has been allocated such U.S. Term B-3 Loan by the Administrative Agent. 

“U.S. Term B-3 Facility” means the credit facility for the U.S. Term B-3 Loans described in Section 2.1(h) hereof. 
 “U.S. Term B-3 Lender” means a Lender with an outstanding U.S. Term B-3 Commitment or an outstanding U.S. Term B-3 Loan. 

“U.S Term B-3 Loan” means an Additional U.S. Term B-3 Loan or a Loan that is deemed made pursuant to Section 2.1(h) hereof. 

“U.S. Term B-3 Commitment” means, with respect to a Lender, the
agreement of such Lender to exchange the entire principal amount of its U.S. Term B-2 Loans (or such lesser amount allocated to it by the Administrative Agent) for an equal principal amount of U.S. Term B-3 Loans on the Amendment No. 5 Effective Date. 
 “U.S. Term B-3 Loan Percentage” means, for any U.S. Term B-3 Lender, the percentage held by such U.S. Term B-3 Lender of the aggregate
principal amount of all U.S. Term B-3 Loans then outstanding. 
 “U.S. Term B-3 Note” is defined in Section 2.12(d) hereof. 
 “U.S. Term B-3 Termination Date” is defined in Section 2.7(b) hereof. 
 (b)    All
references to “U.S. Term B-2 Facility,” “U.S. Term B-2 Lender,” “U.S. Term B-2 Loan,” “U.S.
Term B-2 Loan Commitment,” “U.S. Term B-2 Loan Percentage,” “U.S. Term B-2 Note” and “U.S. Term B-2 Termination Date” in the Loan Agreement and the Loan Documents shall be deemed to be references to “U.S. Term B-3 Facility,” “U.S. Term B-3 Lender”, “U.S. Term B-3 Loan,” “U.S. Term B-3 Commitment,” “U.S. Term
B-3 Loan Percentage,” “U.S. Term B-3 Note” and “U.S. Term B-3 Termination Date,” respectively (other
than any such references contained in (i) the preliminary statements to the Loan Agreement, (ii) Amendment No. 5, (iii) Section 2.1(b) of the Loan Agreement, (iv) Section 2.10 of the Loan Agreement,
(v) Section 2.17 of the Loan Agreement, (vi) Section 3.2 of the Loan Agreement, (vii) Section 3.3 of the Loan Agreement and (viii) Section 6.10 of the Loan Agreement). 

(c)    The definition of “Adjusted LIBOR” in Section 1.1 of the Loan Agreement is hereby amended by
deleting such definition and replacing it with the following: 

  
 3 

 “Adjusted LIBOR” means, for any Borrowing of Term A Loans,
Revolving Loans that are Eurodollar Loans or Term B Loans that are Eurodollar Loans (other than Eurodollar Loans denominated in Euros), a rate per annum equal to the greater of (i) 0% and (ii) the quotient of (A) LIBOR, divided by
(B) one (1) minus the Reserve Percentage. 
 (d)    Clause (a) of the definition of “Applicable
Margin” in Section 1.1 of the Loan Agreement is hereby amended by deleting such clause and replacing it with the following: 

“(a)    with respect to any U.S. Term B-3 Loan, (i) 2.00% per
annum, in the case of a Eurodollar Loan, and (ii) 1.00% per annum, in the case of a Base Rate Loan;” 
 (e)    The
last paragraph of the definition of “Applicable Margin” in Section 1.1 of the Loan Agreement is hereby amended by replacing it in its entirety with the following: 

“Each change in the Applicable Margin under clauses (b) or (c) above resulting from a change in the Leverage Ratio shall be effective
on and after the date of delivery to the Administrative Agent of the financial statements required to be delivered pursuant to Section 6.1(a) or (b) and a Compliance Certificate indicating such change until and including the date
immediately preceding the next date of delivery of such financial statements and the related Compliance Certificate indicating another such change. Notwithstanding the foregoing, (x) (i) in the case of clause (b) above, until the Borrower
shall have delivered the financial statements and the related Compliance Certificate covering a period that includes the first full fiscal quarter of the Borrower ended after the Amendment No. 4 Effective Date, the Leverage Ratio shall be
deemed to be in Category 2 for purposes of determining the Applicable Margin and (ii) in the case of clause (c) above, until the Borrower shall have delivered the financial statements and the related Compliance Certificate covering a
period that includes the first full fiscal quarter of the Borrower ended after the Escrow Release Date, the Leverage Ratio shall be deemed to be in Category 3 for purposes of determining the Applicable Margin and (y) during the existence of any
Event of Default under Section 7.1(a), (j) or (k), for purposes of determining the Applicable Margin, the Leverage Ratio shall be deemed to be (i) in the case of clause (b) above, in Category 2 and (ii) in the case of clause
(c) above, in Category 4. In addition, at the option of the Administrative Agent and the Required Lenders, at any time during which the Borrower has failed to deliver the financial statements or the related Compliance Certificate by the date
required thereunder, then the Leverage Ratio shall be deemed to be in the then-existing Category for the purposes of determining the Applicable Margin (but only for so long as such failure continues, after which the Category shall be otherwise as
determined as set forth above).” 
 (f)    The definition of “Loan Documents” in Section 1.1 of the
Loan Agreement is hereby amended by replacing the word “and” prior to “Amendment No. 4” with “,” 

  
 4 

 
and adding immediately prior to the period therein, “ and Amendment No. 5 and Amendment No. 5 Joinder”. 

(g)    Section 2.1 of the Loan Agreement is hereby amended by making clause (h) thereof clause (i) and adding
the following new clause (h): 
 “(h)    Subject to the terms and conditions set forth herein and in
Amendment No. 5, each Rollover U.S. Term B-2 Lender severally agrees to exchange its Exchanged U.S Term B-2 Loans for a like principal amount of U.S. Term B-3 Loans on the Amendment No. 5 Effective Date. Subject to the terms and conditions set forth herein and in Amendment No. 5, each Additional U.S. Term B-3 Lender
severally agrees to make an Additional U.S. Term B-3 Loan to the Borrower on the Amendment No. 5 Effective Date in the principal amount equal to its Additional U.S. Term
B-3 Commitment on the Amendment No. 5 Effective Date. The Borrower shall prepay the Non-Exchanged U.S. Term B-2 Loans with a
like amount of the gross proceeds of the Additional U.S. Term B-3 Loans, concurrently with the receipt thereof. The Borrower shall pay to the U.S. Term B-2 Lenders
immediately prior to the effectiveness of Amendment No. 5 all accrued and unpaid interest on the U.S. Term B-2 Loans to, but not including, the Amendment No. 5 Effective Date on such Amendment
No. 5 Effective Date. The U.S. Term B-3 Loans shall have the same terms as the U.S. Term B-2 Loans as set forth in the Loan Agreement and Loan Documents before
giving effect to Amendment No. 5, except as modified by Amendment No. 5; it being understood that the U.S. Term B-3 Loans (and all principal, interest and other amounts in respect thereof) will
constitute “Obligations” under the Loan Agreement and the other Loan Documents and shall have the same rights and obligations under the Loan Agreement and Loan Documents as the U.S. Term B-2 Loans
prior to the Amendment No. 5 Effective Date. As provided in Section 2.5(a) and subject to the terms hereof, the Borrower may elect that the U.S. Term B-3 Loans comprising the Borrowing hereunder of
U.S. Term B-3 Loans be either Base Rate Loans or Eurodollar Loans.” 

(h)    Section 2.7(b) of the Loan Agreement is hereby amended by replacing it in its entirety with the following: 

“(b)    Scheduled Payments of U.S. Term B-3 Loans. Subject to
Section 2.15, the Borrower shall make principal payments on the U.S. Term B-3 Loans in installments on each Fiscal Quarter End Date, commencing with the first fiscal quarter ended after the Amendment
No. 5 Effective Date, in an aggregate amount equal to 0.25% of the aggregate principal amount of the U.S. Term B-3 Loans made on the Amendment No. 5 Effective Date, in each case per fiscal quarter
(which payments in each case shall be reduced as a result of the application of prepayments in accordance with the order of priority set forth in Section 2.8(a), Section 2.8(c) and Section 2.8(e), as applicable); it being further
agreed that a 

  
 5 

 
final payment comprised of all principal and interest not sooner paid on the U.S. Term B-3 Loans, shall be due and payable on April 29, 2023, the
final maturity thereof (the “U.S. Term B-3 Termination Date”).” 

(i)    Section 2.8(a)(iii) of the Loan Agreement is hereby amended by replacing it in its entirety with the following:

 “(v)    In the event that, on or prior to the date that is six (6) months after the
Amendment No. 5 Effective Date, the Borrower (x) prepays, repays, refinances, substitutes or replaces any U.S. Term B-3 Loans in connection with a Repricing Transaction (including, for the avoidance
of doubt, any prepayment made pursuant to Section 2.8(c)(i) that constitutes a Repricing Transaction), or (y) effects any amendment, waiver or other modification of, or consent under, this Agreement resulting in a Repricing Transaction,
the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable U.S. Term B-3 Lenders, (A) in the case of clause (x), a premium of 1.00% of the aggregate principal
amount of the U.S Term B-3 Loans so prepaid, repaid, refinanced, substituted or replaced and (B) in the case of clause (y), a fee equal to 1.00% of the aggregate principal amount of the U.S. Term B-3 Loans outstanding immediately prior to such amendment, waiver, modification or consent that are the subject of such Repricing Transaction. If, on or prior to the date that is six (6) months after the
Amendment No. 5 Effective Date, all or any portion of the U.S. Term B-3 Loans held by any U.S. Term B-3 Lender are prepaid, repaid, refinanced, substituted or
replaced pursuant to Section 8.5 as a result of, or in connection with, such U.S. Term B-3 Lender being a Non-Consenting Lender with respect to any amendment,
waiver, modification or consent referred to in clause (y) above (or otherwise in connection with a Repricing Transaction), such prepayment, repayment, refinancing, substitution or replacement will be made at 101% of the principal amount so
prepaid, repaid, refinanced, substituted or replaced. All such amounts shall be due and payable on the date of effectiveness of such Repricing Transaction.” 

(j)    Section 2.10 of the Loan Agreement is hereby amended by adding the following sentence after the fifth sentence in
such section: 
 “The U.S. Term B-3 Commitments and Additional U.S. Term B-3 Commitments shall automatically terminate upon the making, conversion or continuance, as applicable, of the U.S. Term B-3 Loans on the Amendment No. 5 Effective
Date.” 
 (k)    The first sentence in Section 2.12(d) of the Loan Agreement is hereby amended by replacing it
in its entirety with the following: 
 “Any Lender may request that its Loans be evidenced by a promissory note or notes in the forms of
Exhibit D-1 (in the case of its Term A Loan and referred to herein as a “Term A Note”), Exhibit D-2 (in the case of its U.S. Term B-3 Loan and referred to herein as a “U.S. Term B-3 Note”), Exhibit D-3 (in the case of its Euro Term B-2 Loan and referred to herein as a “Euro Term B-2 Note”), Exhibit D-4 (in the case of its Revolving Loans and
referred to herein as a “Revolving  

  
 6 

 
Note”), as applicable (the Term A Notes, U.S. Term B-3 Notes, Euro Term B-2 Notes and Revolving Notes
being hereinafter referred to collectively as the “Notes” and individually as a “Note”).” 

(l)    Exhibit D-2 to the Loan Agreement is hereby amended and restated in its
entirety in the form of Annex A hereto. 
 (m)    Section 6.10 of the Loan Agreement is hereby amended by adding
the following immediately after the eighth sentence thereof: 
 “The Borrower shall use the proceeds of the U.S. Term B-3 Loans on the Amendment No. 5 Effective Date to refinance the U.S. Term B-2 Loans.” 

(n)    Each Lender delivering a Consent or a Joinder hereunder waives, any right to compensation for losses, expenses or
liabilities incurred by such Lender to which it may otherwise be entitled pursuant to Section 8.1 of the Loan Agreement in respect of the transactions contemplated hereby. 

Section 2.    Representations and Warranties. 

Each Loan Party represents and warrants to the Lenders as of the Amendment No. 5 Effective Date that: 

(a)    Immediately before and after giving effect to this Amendment, each of the representations and warranties set forth
in the Loan Agreement and in the other Loan Documents shall be and remain true and correct in all material respects (or, if qualified as to “materiality,” “material adverse effect” or similar language, shall be true and correct
in all respects (after giving effect to any such qualification therein)) as of said time, except to the extent the same expressly relate to an earlier date. 

(b)    At the time of and after giving effect to this Amendment, no Default or Event of Default shall have occurred and be
continuing. 
 Section 3.    Conditions to Effectiveness. 

This Amendment shall become effective on the date on which each of the following conditions is satisfied (the “Amendment
No. 5 Effective Date”): 
 (a)    The Administrative Agent’s receipt of the following,
each of which shall be originals or facsimiles or electronic copies (and, to the extent requested by the Administrative Agent, followed promptly by originals) unless otherwise specified: 

(1)    counterparts of this Amendment executed by each of the Loan Parties; and 

  
 7 

 (2)    a U.S. Term
B-3 Note executed by the Borrower in favor of each U.S. Term B-3 Lender requesting a U.S. Term B-3 Note at least two
(2) Business Days prior to the Amendment No. 5 Effective Date, if any. 
 (b)    The Administrative
Agent’s receipt of the following, each of which shall be originals or facsimiles or electronic copies (and, to the extent requested by the Administrative Agent, followed promptly by originals) unless otherwise specified; 

(1)    (A) a favorable written opinion (addressed to the Administrative Agent and the Lenders) of Cleary
Gottlieb Steen & Hamilton LLP, special counsel to the Loan Parties and (B) a favorable written opinion (addressed to the Administrative Agent and the Lenders) of Young Conaway Stargatt & Taylor, LLP, local counsel to the
Borrower and the Guarantors in the state of Delaware; 
 (2)    (i) copies of the certificate of
formation, certificate of incorporation, certificate of organization, operating agreement, articles of incorporation, memorandum and articles of association and bylaws, as applicable (or comparable organizational documents) of the Borrower and the
Guarantors and, to the extent applicable, certified as of a recent date by the appropriate governmental official (or a representation that such documents have not been amended since the Escrow Release Date); (ii) incumbency certificates of the
officers of such Person executing the Loan Documents to which it is a party as of the Amendment No. 5 Effective Date and prior to the funding of the U.S. Term B-3 Loans; (iii) resolutions of the
board of directors or similar governing body of the Loan Parties approving and authorizing the execution, delivery and performance of this Agreement and the other Loan Documents to which such Loan Party is a party as of the Amendment No. 5
Effective Date and prior to the funding of the U.S. Term B-3 Loans, certified as of the Amendment No. 5 Effective Date by such Loan Party as being in full force and effect without modification or
amendment; and (iv) copies of the certificates of good standing or the equivalent (if any) for each Loan Party from the office of the secretary of state or other appropriate governmental department or agency of the state of its formation,
incorporation or organization, in each case dated a recent date prior to the Amendment No. 5 Effective Date; and 

(3)    a certificate signed by a Responsible Officer of the Borrower certifying as to the satisfaction of
the conditions set forth in Section 2.16(a)(v) of the Loan Agreement with respect to the U.S. Term B-3 Loans and in paragraphs (g) and (h) of this Section 3 as of the Amendment No. 5
Effective Date. 
 (c)    the existing U.S. Term B-2 Loans shall be repaid with
the proceeds of the U.S. Term B-3 Loans substantially simultaneously with effectiveness of this Amendment and the Borrower shall have delivered a prepayment notice with respect to such repayment as required by
Section 2.8(a)(i) of the Loan Agreement; provided that the parties hereto agree that such prepayment notice may be delivered by 1:00 p.m., New York City time, one Business Day before the date of the proposed repayment. 

  
 8 

 (d)    The aggregate principal amount of the Exchanged U.S. Term B-2 Loans plus the aggregate principal amount of the Additional U.S. Term B-3 Commitments shall equal the aggregate principal amount of the outstanding U.S. Term B-2 Loans immediately prior to the Amendment No. 5 Effective Date. 
 (e)    The
Borrower shall have paid to the Administrative Agent, for the ratable account of the U.S. Term B-2 Lenders immediately prior to the Amendment No. 5 Effective Date, all accrued and unpaid interest on the
U.S. Term B-2 Loans to, but not including, the Amendment No. 5 Effective Date. 

(f)    All reasonable and documented
out-of-pocket fees and expenses due to the Administrative Agent and Merrill Lynch required to be paid on the Amendment No. 5 Effective Date (including pursuant to
Section 9 hereof) shall have been paid (or the Borrower shall have made arrangements reasonably satisfactory to the Administrative Agent for such payment). 

(g)    At the time and immediately after giving effect to the incurrence of the U.S. Term
B-3 Loans, no Default or Event of Default shall have occurred and be continuing. 

(h)    Each of the representations and warranties of the Loan Parties set forth in the Loan Agreement, Section 2 of
this Amendment and in the other Loan Documents shall be and remain true and correct in all material respects (or, if qualified as to “materiality,” “material adverse effect” or similar language, shall be true and correct in all
respects (after giving effect to any such qualification therein)) as of the Amendment No. 5 Effective Date, except to the extent the same expressly relate to an earlier date. 

(i)    The Administrative Agent shall have received, no later than 3 Business Days in advance of the Amendment No. 5
Effective Date, all documentation and other information about the Loan Parties as shall have been reasonably requested in writing at least seven (7) Business Days prior to the Amendment No. 5 Effective Date by the U.S. Term B-3 Lenders through the Administrative Agent that is required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation
the Patriot Act. 
 (j)    The Administrative Agent shall have received the Notice of Borrowing required by
Section 2.5 of the Loan Agreement; provided that the parties hereto agree that (i) any Notice of Borrowing in respect of the U.S. Term B-3 Loans requested under this Amendment may be delivered
by 1:00 p.m., New York City time, one Business Day before the date of the proposed Borrowing for such U.S. Term B-3 Loans and (ii) the Notice of Borrowing in respect of such U.S. Term B-3 Loans may be made conditional on the effectiveness of this Amendment. 

(k)    The Administrative Agent shall have received the executed counterparts of the Joinder executed by the Borrower and
each Additional U.S. Term B-3 Lender. 
 (l)    The Administrative Agent shall
have received a completed “Life-of-Loan” Federal Emergency Management Agency standard flood hazard determination with respect to

  
 9 

 
each Mortgaged Property (together with a notice about special flood hazard area status and flood disaster assistance duly executed by the Borrower and each other Loan Party relating thereto).

 The Administrative Agent shall notify the Borrower and the Lenders of the Amendment No. 5 Effective Date and such notice shall be conclusive and
binding. Notwithstanding the foregoing, the amendments effected hereby shall not become effective, the obligations of the Additional U.S. Term B-3 Lenders to make Additional U.S. Term B-3 Loans will automatically terminate, if each of the conditions set forth or referred to in this Section 3 has not been satisfied at or prior to 5:00 p.m., New York City time, on November 8, 2017. 

Section 4.    Formal Requests Deemed Made. 

By its execution of this Amendment, the Borrower hereby delivers and the Administrative Agent hereby acknowledges receipt of this Amendment as
the satisfaction of the requirements to give notice required to the Administrative Agent pursuant to Section 2.16(a) of the Loan Agreement. 

Section 5.    Acknowledgments.  

Each Loan Party hereby expressly acknowledges the terms of this Amendment and reaffirms, as of the date hereof, (i) the covenants and
agreements contained in each Loan Document to which it is a party, including, in each case, such covenants and agreements as in effect immediately after giving effect to this Amendment and the transactions contemplated hereby, (ii) its
guarantee of the Obligations (including, without limitation, the U.S. Term B-3 Loans) pursuant to the Collateral Documents and (iii) its grant of Liens on the Collateral to secure the Obligations
(including, without limitation, the Obligations with respect to the U.S. Term B-3 Loans) pursuant to the Collateral Documents. 

Section 6.    Liens Unimpaired.  

After giving effect to this Amendment, neither the modification of the Loan Agreement effected pursuant to this Amendment nor the execution,
delivery, performance or effectiveness of this Amendment: 
 (a)    impairs the validity, effectiveness or priority of
the Liens granted pursuant to any Loan Document (including, for the avoidance of doubt, any Cayman Islands law governed share mortgage granted by any Loan Party), and such Liens continue unimpaired with the same priority to secure repayment of all
Obligations, whether heretofore or hereafter incurred; or 
 (b)    requires that any new filings be made or other
action taken to perfect or to maintain the perfection of such Liens. 
 Section 7.    Entire Agreement. 

 This Amendment, the Loan Agreement and the other Loan Documents constitute the entire agreement among the parties hereto with respect
to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, 

  
 10 

 
among the parties hereto with respect to the subject matter hereof. Except as expressly set forth herein, this Amendment and the Loan Agreement shall not by implication or otherwise limit,
impair, constitute a waiver of, or otherwise affect the rights and remedies of any party under, the Loan Agreement, nor alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the
Loan Agreement, all of which are ratified and affirmed in all respects and shall continue in full force and effect. This Amendment shall not constitute a novation of the Loan Agreement or any of the Loan Documents. It is understood and agreed that
each reference in each Loan Document to the “Loan Agreement,” whether direct or indirect, shall hereafter be deemed to be a reference to the Loan Agreement as amended by this Amendment and that this Amendment is a “Loan Document”
and a “Refinancing Amendment.” 
 Section 8.    Amendment, Modification and Waiver. 

This Amendment may not be amended, modified or waived except pursuant to a writing signed by each of the parties hereto. 

Section 9.    Expenses. 

The Borrower agrees to reimburse the Administrative Agent for its reasonable and documented out-of-pocket expenses incurred by them in connection with this Amendment, including the reasonable and documented fees, charges and disbursements of Cahill Gordon & Reindel LLP,
counsel for the Administrative Agent. 
 Section 10.    Counterparts. 

This Amendment may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of which when so
executed and delivered shall be deemed to be an original, but all of which when taken together shall constitute a single instrument. Delivery of an executed counterpart of a signature page of this Amendment by facsimile transmission or electronic
transmission shall be effective as delivery of a manually executed counterpart hereof. 

Section 11.    Governing Law and Waiver of Right to Trial by Jury. 

THIS AMENDMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE
PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. SECTION 10.22 OF THE LOAN AGREEMENT IS HEREBY INCORPORATED BY REFERENCE INTO THIS AMENDMENT AND SHALL APPLY
HERETO. 
 Section 12.    Headings. 

The headings of this Amendment are for purposes of reference only and shall not limit or otherwise affect the meaning hereof. 

  
 11 

 Section 13.    Effect of Amendment. 

Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise
affect the rights and remedies of the Lenders or the Administrative Agent under the Loan Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements
contained in the Loan Agreement or any other provision of the Loan Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. 

Section 14.    Mortgage Amendments. 

Within ninety (90) days after the Amendment No. 5 Effective Date, unless waived or extended by the Administrative Agent in its sole
discretion, with respect to each Mortgaged Property, the Administrative Agent shall have received either the items listed in paragraph (a) or the items listed in paragraph (b) as follows: 

(a)    a favorable opinion or email confirmation, in form and substance reasonably satisfactory to the
Administrative Agent, from local counsel in the jurisdiction in which each Mortgaged Property is located substantially to the effect that: 

(i)    the recording of the existing Mortgage is the only filing or recording necessary to give
constructive notice to third parties of the lien created by such Mortgage as security for the Obligations, including the Obligations evidenced by the Loan Agreement and the other documents executed in connection therewith, for the benefit of the
Secured Parties; and 
 (ii)    no other documents, instruments, filings, recordings, re-recordings, re-filings or other actions, including, without limitation, the payment of any mortgage recording taxes or similar taxes, are necessary or appropriate under
applicable law in order to maintain the continued enforceability, validity or priority of the lien created by such Mortgage as security for the Obligations, including the Obligations evidenced by the Loan Agreement and the other documents executed
in connection therewith, for the benefit of the Secured Parties; or 
 (b)    with respect to the
existing Mortgages, the following, in each case in form and substance reasonably acceptable to the Administrative Agent: 

(i)    an amendment to the existing Mortgage (the “Mortgage Amendment”) to reflect the
matters set forth in this Amendment, duly executed and acknowledged by the applicable Loan Party, and in form for recording in the recording office where such Mortgage was recorded, together with such certificates, affidavits, questionnaires or
returns as shall be required in connection with the recording or filing thereof under applicable law; 

(ii)    a favorable opinion, addressed to the Administrative Agent and the Secured Parties covering, among
other things, the due authorization, execution, 

  
 12 

 
delivery and enforceability of the applicable Mortgage as amended by the Mortgage Amendment (such opinion may take assumptions for any matters addressed in the local counsel opinion originally
delivered in connection with the Mortgage); 
 (iii)    a date down endorsement to the existing title
policy, which shall be in form and substance reasonably satisfactory to the Administrative Agent and reasonably assure the Administrative Agent as of the date of such endorsement that the real property subject to the lien of such Mortgage is free
and clear of all defects and encumbrances except those Liens permitted under such Mortgage; 

(iv)    evidence of payment by the Borrower of all search and examination charges escrow charges and
related charges, mortgage recording taxes, fees, charges, costs and expenses required for the recording of the Mortgage Amendment referred to above; and 

(v)    such affidavits, certificates, information and instruments of indemnification as shall be required
to induce the title insurance company to issue the endorsement to the title policy contemplated in this Section 14 and evidence of payment of all applicable title insurance premiums, search and examination charges, mortgage recording taxes and
related charges required for the issuance of the endorsement to the title policy contemplated in this Section 14. 

  
 13 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the
date first above written. 
  

					
	WESTERN DIGITAL CORPORATION
		
	By:	 	               /s/ Mark
Long

		 	Name:	 	Mark Long
		 	Title:	 	President WD Capital, Chief Strategy Officer and Chief Financial Officer

  
 [SIGNATURE PAGE TO
AMENDMENT NO. 5] 

 
					
	HGST, INC.
		
	By:	 	            /s/ Michael C.
Ray

		 	Name:	 	Michael C. Ray
		 	Title:	 	President and Secretary
	
	WD MEDIA, LLC
		
	By:	 	            /s/ Michael C.
Ray

		 	Name:	 	Michael C. Ray
		 	Title:	 	Secretary
	
	WESTERN DIGITAL (FREMONT), LLC
		
	By:	 	            /s/ Michael C.
Ray

		 	Name:	 	Michael C. Ray
		 	Title:	 	Vice President and Secretary
	
	WESTERN DIGITAL TECHNOLOGIES, INC.
		
	By:	 	            /s/ Michael C.
Ray

		 	Name:	 	Michael C. Ray
		 	Title:	 	Executive Vice President, Chief
		 		 	Legal Officer and Secretary

  
 [SIGNATURE PAGE TO
AMENDMENT NO. 5] 

 
					
	JPMORGAN CHASE BANK, N.A., as
    Administrative Agent
		
	By:	 	               /s/
Caitlin Stewart

		 	Name:	 	Caitlin Stewart
		 	Title:	 	Vice President

  
 [SIGNATURE PAGE TO
AMENDMENT NO. 5] 

 EXHIBIT A 

CONSENT TO CASHLESS ROLL 
 CONSENT TO
CASHLESS ROLL (this “Consent”) in connection with Amendment No. 5 (“Amendment”) to that certain Loan Agreement, dated as of April 29, 2016 (as extended, renewed, amended, restated, amended and restated,
supplemented or otherwise modified from time to time, the “Loan Agreement”), by and among Western Digital Corporation (the “Borrower”), JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative
Agent”), the Lenders from time to time party thereto and the other parties thereto. Unless otherwise defined herein, terms defined in the Loan Agreement and used herein shall have the meanings given to them in the Amendment. 

Existing U.S. Term B-2 Lenders / Cashless Settlement 

The undersigned U.S. Term B-2 Lender hereby irrevocably and unconditionally consents to convert 100% of the outstanding
principal amount of the U.S. Term B-2 Loan held by such U.S. Term B-2 Lender (or such lesser amount allocated to such Lender by the Administrative Agent) into a U.S.
Term B-3 Loan in a like principal amount via a cashless roll. 
 IN WITNESS WHEREOF, the undersigned has caused this
Consent to be executed and delivered by a duly authorized officer. 
  

			
	Date:             , 2017
	
	                                    
                                        
,
	as a Lender (type name of the legal entity)
		
	By:	 	
                     
                                        

		 	Name:
		 	Title:
	
	If a second signature is necessary:
		
	By:	 	
                     
                                        

		 	Name:
		 	Title:

 EXHIBIT B 

JOINDER AGREEMENT 

JOINDER AGREEMENT, dated as of November 8, 2017 (this “Agreement”), by and among BANK OF AMERICA, N.A. (the
“U.S. Term B-3 Lender”), Western Digital Corporation (the “Borrower”), and JPMORGAN CHASE BANK, N.A. (the “Administrative Agent”). 

RECITALS: 
 WHEREAS,
reference is hereby made to the Loan Agreement, dated as of April 29, 2016, as amended by Amendment No. 1, dated as of August 17, 2016, Amendment No. 2, dated as of September 22, 2016, Amendment No. 3, dated as of
March 14, 2017 and Amendment No. 4, dated as of March 23, 2017 (as further amended, restated, extended, supplemented or otherwise modified in writing from time to time, the “Loan Agreement”), among the Borrower, each
lender from time to time party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent and the other parties thereto (capitalized terms used but not defined herein having the meaning provided in the Loan Agreement (as amended by Amendment
No. 5)); 
 WHEREAS, subject to the terms and conditions of the Loan Agreement, the Borrower may establish the Additional U.S. Term B-3 Commitment with existing U.S. Term B-2 Lenders and/or Additional U.S. Term B-3 Lenders; and 

WHEREAS, subject to the terms and conditions of Amendment No. 5, Additional U.S. Term B-3 Lenders
shall become Lenders pursuant to one or more Joinders (as defined in Amendment No. 5); 
 NOW, THEREFORE, in consideration of the
premises and agreements, provisions and covenants herein contained, the parties hereto agree as follows: 
 Each Additional U.S. Term B-3 Lender hereby agrees to provide the Additional U.S. Term B-3 Commitment set forth on its signature page hereto pursuant to and in accordance with Section 2.1(h) of
the Loan Agreement. The Additional U.S. Term B-3 Commitment provided pursuant to this Agreement shall be subject to all of the terms in the Loan Agreement and to the conditions set forth in the Loan Agreement,
and shall be entitled to all the benefits afforded by the Loan Agreement and the other Loan Documents, and shall, without limiting the foregoing, benefit equally and ratably from the Guaranty and security interests created by the Collateral
Documents. 
 Each Additional U.S. Term B-3 Lender, the Borrower and the Administrative Agent
acknowledge and agree that the Additional U.S. Term B-3 Commitment provided pursuant to this Agreement shall constitute Additional U.S. Term B-3 Commitments for all
purposes of the Loan Agreement and the other applicable Loan Documents. Each Additional U.S. Term B-3 Lender hereby agrees to make an Additional U.S. Term B-3 Loan to
the Borrower in an 

 
amount equal to its Additional U.S. Term B-3 Commitment on the Amendment No. 5 Effective Date in accordance with Section 2.1(h) of the Loan
Agreement. 
 Each Additional U.S. Term B-3 Lender (i) confirms that it has received a copy of
the Loan Agreement and the other Loan Documents, together with copies of the financial statements referred to therein and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into
this Agreement; (ii) agrees that it will, independently and without reliance upon the Administrative Agent, the Joint Lead Arrangers or any other Additional U.S. Term B-3 Lender or any other Lender and
based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Agreement; (iii) appoints and authorizes the Administrative Agent to take
such action as agent on its behalf and to exercise such powers and discretion under the Loan Agreement and the other Loan Documents as are delegated to the Administrative Agent by the terms thereof, together with such powers and discretion as are
reasonably incidental thereto; and (iv) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the Loan Agreement are required to be performed by it as a Lender. 

Upon (i) the execution of a counterpart of this Agreement by each Additional U.S. Term B-3
Lender, the Administrative Agent and the Borrower and (ii) the delivery to the Administrative Agent of a fully executed counterpart (including by way of telecopy or other electronic transmission) hereof, each of the undersigned Additional U.S.
Term B-3 Lenders shall become Lenders under the Loan Agreement and shall have the respective Additional U.S. Term B-3 Commitment set forth on its signature page hereto,
effective as of the Amendment No. 5 Effective Date. 
 For each Additional U.S. Term B-3
Lender, delivered herewith to the Administrative Agent are such forms, certificates or other evidence with respect to United States federal income tax withholding matters as such Additional U.S. Term B-3
Lender may be required to deliver to the Administrative Agent pursuant to Section 10.1 of the Loan Agreement. 
 This Agreement may not
be amended, modified or waived except by an instrument or instruments in writing signed and delivered on behalf of each of the parties hereto. 

This Agreement, the Loan Agreement and the other Loan Documents constitute the entire agreement among the parties with respect to the subject
matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof. 

THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF
THE STATE OF NEW YORK. 

  
 B-2 

 Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction
shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of
the terms or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as would be enforceable. 

This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the
same agreement. 

  
 B-3 

 IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to execute and
deliver this Joinder Agreement as of date first written above. 
  

			
	BANK OF AMERICA, N.A.
		
	By:	 	
                     
                    

		 	Name:
		 	Title:
	
	Additional U.S. Term B-3 Commitments:
	$173,564,777.80
	
	WESTERN DIGITAL CORPORATION
		
	By:	 	
                     
                    

		 	Name:
		 	Title:

  
 B-4 

			
	Accepted:
	
	 JPMORGAN CHASE BANK, N.A.,
 as
Administrative Agent

		
	By:	 	
                     
                    

		 	Name:
		 	Title:

  
 B-5 

 EXHIBIT D-2 

EXHIBIT D-2 

U.S. TERM B-3 NOTE 
  

	
$                         
    
	             , 20    

 FOR VALUE RECEIVED, the undersigned, Western Digital Corporation, a
Delaware corporation (the “Borrower”), hereby promises to pay to          or its registered assigns (the “Lender”) at the principal office of JPMorgan Chase Bank, N.A.,
as Administrative Agent, in New York, New York, in immediately available funds, the principal sum of          Dollars ($        ) or, if less, the
aggregate unpaid principal amount of the U.S. Term B-3 Loan made or maintained by the Lender to the Borrower pursuant to the Loan Agreement (as defined below), in installments in the amounts and on the dates
called for by Section 2.7(b) of the Loan Agreement, together with interest on the principal amount of such U.S. Term B-3 Loan from time to time outstanding hereunder at the rates, and payable in the
manner and on the dates, specified in the Loan Agreement. 
 This Note is one of the U.S. Term B-3
Notes referred to in the Loan Agreement dated as of April 29, 2016 among the Borrower, JPMorgan Chase Bank, N.A., as Administrative Agent, the Lenders party thereto from time to time, and the other agents party thereto (as extended, renewed,
amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Loan Agreement”), and this Note and the holder hereof are entitled to all the benefits and security provided for thereby or referred
to therein, to which Loan Agreement reference is hereby made for a statement thereof. All defined terms used in this Note, except terms otherwise defined herein, shall have the same meaning as in the Loan Agreement. This Note shall be governed by
and construed in accordance with the laws of the State of New York. 
 Voluntary prepayments may be made hereon, certain prepayments are
required to be made hereon, and this Note may be declared due prior to the expressed maturity hereof, all on the terms and in the manner as provided for in the Loan Agreement. 

The Borrower hereby waives demand, presentment, protest or notice of any kind hereunder. 

 

			
	WESTERN DIGITAL CORPORATION
		
	By:	 	
                     
                    

		 	Name:
		 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]